The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tatsis Ourania since 2019.
This trader's CIK number is 1789815.
At the time of last reporting, Tatsis Ourania was the EVP, Chief Reg. & Quality Off. of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX).
Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | VRTX | 0 | $0 | 8,494 | $4,155,818 | 0 | $0 |
| 2024 | VRTX | 0 | $0 | 3,329 | $1,486,271 | 0 | $0 |
| 2023 | VRTX | 0 | $0 | 7,179 | $2,408,576 | 0 | $0 |
| 2022 | VRTX | 0 | $0 | 5,077 | $1,324,836 | 0 | $0 |
| 2020 | VRTX | 0 | $0 | 6,303 | $1,525,175 | 3,608 | $645,717 |
| 2019 | VRTX | 0 | $0 | 3,490 | $693,823 | 2,853 | $443,841 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-10 | VRTX | Sale | 3,242 | 499.99 | 1,620,967 |
| 2025-03-04 | VRTX | Sale | 4,058 | 485.49 | 1,970,118 |
| 2025-02-27 | VRTX | Sale | 530 | 475.34 | 251,930 |
| 2025-02-25 | VRTX | Sale | 354 | 480.95 | 170,256 |
| 2025-02-11 | VRTX | Sale | 310 | 459.83 | 142,547 |
| 2024-06-03 | VRTX | Sale | 2,175 | 460.00 | 1,000,500 |
| 2024-02-21 | VRTX | Sale | 360 | 421.77 | 151,837 |
| 2024-02-20 | VRTX | Sale | 480 | 420.79 | 201,979 |
| 2024-02-12 | VRTX | Sale | 314 | 420.24 | 131,955 |
| 2023-08-10 | VRTX | Sale | 5,750 | 345.79 | 1,988,292 |
| 2023-02-27 | VRTX | Sale | 354 | 288.27 | 102,048 |
| 2023-02-21 | VRTX | Sale | 480 | 293.12 | 140,695 |
| 2023-02-14 | VRTX | Sale | 320 | 298.11 | 95,393 |
| 2023-02-13 | VRTX | Sale | 275 | 298.72 | 82,148 |
| 2022-08-09 | VRTX | Sale | 1,400 | 299.68 | 419,554 |
| 2022-03-17 | VRTX | Sale | 2,833 | 250.67 | 710,148 |
| 2022-02-25 | VRTX | Sale | 325 | 230.94 | 75,056 |
| 2022-02-18 | VRTX | Sale | 519 | 231.37 | 120,078 |
| 2020-05-15 | VRTX | Sale | 120 | 283.42 | 34,010 |
| 2020-05-06 | VRTX | Option Ex | 966 | 171.55 | 165,717 |
| 2020-05-06 | VRTX | Sale | 966 | 272.28 | 263,019 |
| 2020-02-25 | VRTX | Sale | 1,296 | 233.57 | 302,713 |
| 2020-02-18 | VRTX | Sale | 1,279 | 243.82 | 311,850 |
| 2020-02-06 | VRTX | Sale | 967 | 240.41 | 232,471 |
| 2020-02-06 | VRTX | Option Ex | 967 | 171.55 | 165,888 |
| 2020-01-08 | VRTX | Option Ex | 1,675 | 187.53 | 314,112 |
| 2020-01-08 | VRTX | Sale | 1,675 | 227.53 | 381,112 |
| 2019-11-15 | VRTX | Sale | 5 | 205.95 | 1,029 |
| 2019-11-13 | VRTX | Sale | 2,853 | 205.59 | 586,548 |
| 2019-11-13 | VRTX | Option Ex | 2,853 | 155.57 | 443,841 |
| 2019-10-01 | VRTX | Sale | 188 | 169.11 | 31,792 |
| 2019-10-02 | VRTX | Sale | 444 | 167.69 | 74,454 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tatsis Ourania (EVP, Chief Reg. & Quality Off. of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.